Overview

Inhaled Nitric Oxide for Preventing Chronic Lung Disease in Premature Infants

Status:
Completed
Trial end date:
2007-10-01
Target enrollment:
Participant gender:
Summary
To determine whether or not inhaled nitric oxide (iNO) safely decreases the incidence of chronic lung disease (CLD) in premature infants.
Phase:
Phase 3
Details
Lead Sponsor:
University of Colorado, Denver
Collaborator:
National Heart, Lung, and Blood Institute (NHLBI)
Treatments:
Nitric Oxide